Alpha Dna Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Alpha Dna Investment Management LLC
- $267 Million
- Q1 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 606 shares of REGN stock, worth $620,598. This represents 0.22% of its overall portfolio holdings.
Number of Shares
606
Previous 1,341
54.81%
Holding current value
$620,598
Previous $1.18 Million
50.47%
% of portfolio
0.22%
Previous 0.47%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,427Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.15 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.78 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.91 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.96 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.77 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $110B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...